Schrodinger Companies
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas.
Founded Date:
1990
Investor Type:
Venture Capital Funds
Employee Number:
501-1000
Headquarters:
New York
Estimated Revenue:
$35.29M
